ABL Biotech is setting up a 100 crore facility to manufacture DHA and EHA at the Marine Biotech Park at Visakhapatnam. It would be the World's 2nd India's 1st DHA, EHA facility.

The AP Government has developed a Marine Biotech Park in Visakhapatman, India modeled on the lines of SP Biotech Park of Genome valley. One of its first occupents, Celgen Biologicals Pvt Ltd (Celgen), a wholly owned subsidiary of ABL Biotechnologies, is in the process of establishing India's first facility for the production of the essential fatty acid DHA at Visakhapatnam.